Development of a multivariate prediction model of intensive care unit transfer or death: A French prospective cohort study of hospitalized COVID-19 patients.
Aged
Aged, 80 and over
Betacoronavirus
/ genetics
COVID-19
Coronavirus Infections
/ epidemiology
Female
Forecasting
/ methods
Hospital Mortality
/ trends
Hospitalization
Humans
Intensive Care Units
Male
Middle Aged
Pandemics
Paris
/ epidemiology
Patient Discharge
Patient Transfer
/ trends
Pneumonia, Viral
/ epidemiology
Prognosis
Prospective Studies
Real-Time Polymerase Chain Reaction
Reverse Transcriptase Polymerase Chain Reaction
SARS-CoV-2
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
14
05
2020
accepted:
01
10
2020
entrez:
19
10
2020
pubmed:
20
10
2020
medline:
3
11
2020
Statut:
epublish
Résumé
Prognostic factors of coronavirus disease 2019 (COVID-19) patients among European population are lacking. Our objective was to identify early prognostic factors upon admission to optimize the management of COVID-19 patients hospitalized in a medical ward. This French single-center prospective cohort study evaluated 152 patients with positive severe acute respiratory syndrome coronavirus 2 real-time reverse transcriptase-polymerase chain reaction assay, hospitalized in the Internal Medicine and Clinical Immunology Department, at Pitié-Salpêtrière's Hospital, in Paris, France, a tertiary care university hospital. Predictive factors of intensive care unit (ICU) transfer or death at day 14 (D14), of being discharge alive and severe status at D14 (remaining with ventilation, or death) were evaluated in multivariable logistic regression models; models' performances, including discrimination and calibration, were assessed (C-index, calibration curve, R2, Brier score). A validation was performed on an external sample of 132 patients hospitalized in a French hospital close to Paris, in Aulnay-sous-Bois, Île-de-France. The probability of ICU transfer or death was 32% (47/147) (95% CI 25-40). Older age (OR 2.61, 95% CI 0.96-7.10), poorer respiratory presentation (OR 4.04 per 1-point increment on World Health Organization (WHO) clinical scale, 95% CI 1.76-9.25), higher CRP-level (OR 1.63 per 100mg/L increment, 95% CI 0.98-2.71) and lower lymphocytes count (OR 0.36 per 1000/mm3 increment, 95% CI 0.13-0.99) were associated with an increased risk of ICU requirement or death. A 9-point ordinal scale scoring system defined low (score 0-2), moderate (score 3-5), and high (score 6-8) risk patients, with predicted respectively 2%, 25% and 81% risk of ICU transfer or death at D14. Therefore, in this prospective cohort study of laboratory-confirmed COVID-19 patients hospitalized in a medical ward in France, a simplified scoring system at admission predicted the outcome at D14.
Identifiants
pubmed: 33075088
doi: 10.1371/journal.pone.0240711
pii: PONE-D-20-14374
pmc: PMC7571674
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0240711Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Références
Int J Infect Dis. 2020 May;94:154-155
pubmed: 32179137
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Lancet Infect Dis. 2020 Jun;20(6):669-677
pubmed: 32240634
Stat Med. 2019 Mar 30;38(7):1276-1296
pubmed: 30357870
Clin Infect Dis. 2020 Jul 28;71(15):748-755
pubmed: 32239127
BMJ. 2020 Apr 7;369:m1328
pubmed: 32265220
JAMA. 2020 Apr 28;323(16):1545-1546
pubmed: 32167538
J Infect. 2020 Jun;80(6):639-645
pubmed: 32240670
Eur Respir J. 2020 May 14;55(5):
pubmed: 32217650
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524
Stat Med. 2019 Mar 30;38(7):1262-1275
pubmed: 30347470
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
J Clin Invest. 2020 May 1;130(5):2620-2629
pubmed: 32217835
Ann Med. 2020 Nov;52(7):367-375
pubmed: 32723107
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Chest. 2020 Jul;158(1):106-116
pubmed: 32275978
Euro Surveill. 2020 Mar;25(10):
pubmed: 32183930